Basic information
Biomarker: cathepsin D
Histology type: endometrial carcinoma
Cohort characteristics
Country: Germany
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
86 | EC | 44 | normal endometrial tissues | 42 |
Sample information
Conclusion: The prognostic value of cathepsin D in endometrial carcinoma.The overexpression of Cathepsin D seems to be important for exact biologic characterization of each endometrial carcinoma with respect to local proteolytic activity. The enhanced activity of cathepsin D may therefore serve as an additional objective malignancy criterion independent of the well-known prognostic factors.
Sample type : tissue
Sample method: RIA
Expression pattern : overexpression
Disease information
Related information
Funtion Uniprot: Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease
UniProt ID: P07339
UniProt Link: https://www.uniprot.org/uniprotkb/P07339/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in the aorta extracellular space (at protein level) (PubMed:20551380). Expressed in liver (at protein level) (PubMed:1426530).
Subcellular UniProt: #Lysosome #Secreted
Cleaved: Cleaved into 2 chains Cathepsin D light chain Cathepsin D heavy chain
Catalytic activity: Specificity similar to, but narrower than, that of pepsin A. Does not cleave the 4-Gln-|-His-5 bond in B chain of insulin.
Recommended name: Cathepsin D
Gene name from HGNC: CTSD (CLN10, CPSD)
HPA class: Cancer-related genes Disease related genes Enzymes Human disease related genes Metabolic proteins Plasma proteins Potential drug targets
AlphaFold DB: P07339
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P07339
HPA link: https://www.proteinatlas.org/ENSG00000117984-CTSD
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Cytoplasmic expression with a granular in all tissues.
Single cell type specificity Cell type enhanced (Hofbauer cells, Proximal enterocytes, Macrophages, Distal enterocytes)
Immune cell specificity: Low immune cell specificity
Cancer prognostic summary HPA Prognostic marker in renal cancer (favorable) and colorectal cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000117984-CTSD/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000117984-CTSD/pathology/endometrial+cancer
Phenotype ID: 610127
Disease: Ceroid lipofuscinosis, neuronal, 10 (CLN10)
Note1: The disease is caused by variants affecting the gene represented in this entry;
OMIM: 116840
OMIM link1: https://www.omim.org/entry/610127
OMIM link2: https://www.omim.org/entry/116840
HGNC ID: HGNC:2529
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:2529